(Q33376161)

26 July 2017

title

Cryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura (English)

1 reference

thrombotic thrombocytopenic purpura

26 July 2017

1 reference

1 reference

Scully M

1

1 reference

26 July 2017

Longair I

2

1 reference

26 July 2017

Flynn M

3

1 reference

26 July 2017

Berryman J

4

1 reference

26 July 2017

Machin SJ

5

1 reference

26 July 2017

publication date

1 August 2007

1 reference

26 July 2017

1 reference

26 July 2017

volume

93

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

154-158

1 reference

Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

Manufacture and composition of fresh frozen plasma and virus-inactivated therapeutic plasma preparations: correlation between composition and therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

Thrombotic thrombocytopaenic purpura in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

The management of thrombotic thrombocytopenic purpura in 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

SD Plasma in TTP and coagulation factor deficiencies for which no concentrates are available

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: is its decreased protein S activity clinically related to their development of deep venous thromboses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

Solvent/detergent-treated plasma: composition, efficacy, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

Role of methylene blue-treated or fresh-frozen plasma in the response to plasma exchange in patients with thrombotic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

Incidence of allergic reactions with fresh frozen plasma or cryo-supernatant plasma in the treatment of thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

Adverse reactions associated with mobile therapeutic apheresis: analysis of 17,940 procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

The Norwegian Plasma Fractionation Project--a 12 year clinical and economic success story

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2007.00940.X

10.1111/J.1423-0410.2007.00940.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference